Medical Cannabis Revisted: A Podcast with David Casarett and Eloise Theisen
GeriPal
OCTOBER 24, 2024
If you believe the evidence for efficacy to manage symptoms like neuropathic pain, how do you even start to think about recommending these products to patients? And you could say the same thing about insurance companies. Insurance companies will pay for a lot of drugs that have really not a whole lot of evidence at a lot of costs.
Let's personalize your content